Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia

Journal of Cellular Biochemistry

Volumn 110, Issue 3, 2010, Pages 697-705

  Lu, Dah Yuu ^a   Tang, Chih Hsin ^a   Chen, Yi Hung ^a   Wei, I Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AMPK; GLIA; IFN ; LPS; Neuroinflammation

Indexed keywords

BERBERINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CYCLOOXYGENASE 2; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 10; PROTEIN KINASE LKB1; PROTEIN SERINE THREONINE KINASE INHIBITOR; SERINE; SYNAPTOPHYSIN; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG INHIBITION; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STIMULATION;

ADENYLATE KINASE; ANIMALS; BERBERINE; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION; INFLAMMATION; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77952700957     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22580     Document Type: Article

References (46)

1. Abidi P, Zhou Y, Jiang JD, Liu J. 2005. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 25:2170-2176. (Pubitemid 41416317)
2. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491. (Pubitemid 32781092)
3. Beckman JS, Chen J, Crow JP, Ye YZ. 1994. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103:371-380.
4. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, Issandou M. 2006. Inhibition of lipid synthesis through activation of AMP kinase: An additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47:1281-1288. (Pubitemid 43830720)
5. Carling D, Sanders MJ, Woods A. 2008. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32(Suppl. 4): S55-S59.
6. Chao CC, Hu S, Peterson PK. 1995. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 58:65-70.
7. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, Nan FJ, Li J. 2006. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta 1760:1682-1689. (Pubitemid 44667275)
8. Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38:599-605.
9. Choi BH, Kim YH, Ahn IS, Ha JH, Byun JM, Do MS. 2009. The inhibition of inflammatory molecule expression on 3T3-L1 adipocytes by berberine is not mediated by leptin signaling. Nutr Res Pract 3:84-88.
10. Culmsee C, Monnig J, Kemp BE, Mattson MP. 2001. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17:45-58. (Pubitemid 32928285)
11. Giri S, Nath N, Smith B, Viollet B, Singh AK, Singh I. 2004. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: A possible role of AMP-activated protein kinase. J Neurosci 24:479-487. (Pubitemid 38112379)
12. Giroux M, Descoteaux A. 2000. Cyclooxygenase-2 expression in macrophages: Modulation by protein kinase C-alpha. J Immunol 165:3985-3991. (Pubitemid 32057309)
13. Hardie DG. 2003. Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology 144:5179-5183.
14. Hardie DG, Sakamoto K. 2006. AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21:48-60. (Pubitemid 43752517)
15. Hardie DG, Carling D, Carlson M. 1998. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821-855.
16. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. 2005. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19. (Pubitemid 43239821)
17. Ho YT, Yang JS, Li TC, Lin JJ, Lin JG, Lai KC, Ma CY, Wood WG, Chung JG. 2009. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 279:155-162.
18. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L, Rider MH. 2006. Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem 281:5335-5340. (Pubitemid 43847626)
19. Hsiang CY, Wu SL, Cheng SE, Ho TY. 2005. Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells. J Biomed Sci 12:791-801.
20. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K. 2008. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 580:70-79.
21. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ, Abraham RT. 2002. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22: 7004-7014.
22. Hurley RL, Barre LK, Wood SD, Anderson KA, Kemp BE, Means AR, Witters LA. 2006. Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281:36662-36672.
23. Ido Y, Carling D, Ruderman N. 2002. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: Inhibition by the AMP-activated protein kinase activation. Diabetes 51:159-167. (Pubitemid 34517993)
24. Jang BC, Paik JH, Kim SP, Shin DH, Song DK, Park JG, Suh MH, Park JW, Suh SI. 2005. Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal 17:625-633.
25. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, Shin HJ, Kim WS, Kim JB. 2009. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296:E955-E964.
26. Kim KW, Ha KT, Park CS, Jin UH, Chang HW, Lee IS, Kim CH. 2007. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Vascul Pharmacol 47:99-107.
27. Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, Oh GT, Park HS, Lee KU, Lane MD, Kim JB. 2009. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab 296:E812-E819.
28. Koistinaho M, Koistinaho J. 2002. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. GLIA 40:175-183. (Pubitemid 35337375)
29. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
30. Kuo CL, Chi CW, Liu TY. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127-137. (Pubitemid 38063132)
31. Lamontagne J, Pepin E, Peyot ML, Joly E, Ruderman NB, Poitout V, Murthy Madiraju SR, Nolan CJ, Prentki M. 2009. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations. Endocrinology 150:3465-3474.
32. Leclerc I, Rutter GA. 2004. AMP-activated protein kinase: A new beta-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes 53(Suppl. 3): S67-S74. (Pubitemid 39564525)
33. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256-2264. (Pubitemid 44743622)
34. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. 2007. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193-201.
35. Liang KW, Ting CT, Yin SC, Chen YT, Lin SJ, Liao JK, Hsu SL. 2006. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol 71:806-817.
36. Loihl AK, Murphy S. 1998. Expression of nitric oxide synthase-2 in glia associated with CNS pathology. Prog Brain Res 118:253-267. (Pubitemid 28530672)
37. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM. 1999. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 274:29138-29148. (Pubitemid 29477078)
38. McCarty MF, Barroso-Aranda J, Contreras F. 2009. Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease. Med Hypotheses 73:1008-1010.
39. Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY. 2007. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7: 1092-1101.
40. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. 2004. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495-503. (Pubitemid 39572099)
41. Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T. 2004. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 67:2005-2011. (Pubitemid 38591388)
42. Uto T, Fujii M, Hou DX. 2007. Effects of 6-(methylsulfinyl)hexyl isothiocyanate on cyclooxygenase-2 expression induced by lipopolysaccharide, interferon-gamma and 12-O-tetradecanoylphorbol-13-acetate. Oncol Rep 17:233-238.
43. Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS, Hong JS, Jeng KC. 2002. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 16:2103-2112.
44. Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM, Xu A. 2009. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 82:484-492.
45. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. 2005. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33. (Pubitemid 43239822)
46. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H, Brecher P, Ruderman NB, Cohen RA. 2004. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279:47898-47905. (Pubitemid 39540941)